PSA test for prostate cancer: information for GPs
Public Health England
Each year in the UK, about 47,000 men are diagnosed with prostate cancer and a further 11,000 die from the disease. Localised prostate testing through digital rectal examination, biopsy, or prostate specific antigen (PSA) analysis can detect the early stages of prostate cancer when it is still practical to cure or slow its progress; evidence suggests that PSA screening could reduce prostate cancer-related mortality by 21%.
This Guidelines summary covers the diagnosis, management, and treatment of prostate cancer. It also includes an algorithm on PSA testing and the prostate cancer patient pathway.